Linkage of Crohn's Disease to the Major Histocompatibility Complex Region is Detected by Multiple Non-parametric Analyses
Overview
Affiliations
Background: There is evidence for genetic susceptibility to Crohn's disease, and a tentative association with tumour necrosis factor (TNF) and HLA class II alleles.
Aims: To examine the potential of genetic linkage between Crohn's disease and the MHC region on chromosome 6p.
Methods: TNF microsatellite markers and, for some families, additional HLA antigens were typed for 323 individuals from 49 Crohn's disease multiplex families to generate informative haplotypes. Non-parametric linkage analysis methods, including sib pair and affected relative pair methods, were used.
Results: Increased sharing of haplotypes was observed in affected sib pairs: 92% (48/52) shared one or two haplotypes versus an expected 75% if linkage did not exist (p=0.004). After other affected relative pairs were included, the significance level reached 0.001. The mean proportion of haplotype sharing was increased for both concordant affected (pi=0.60, p=0.002) and unaffected sib pairs (pi=0.58, p=0. 031) compared with the expected value (pi=0.5). In contrast, sharing in discordant sib pairs was significantly decreased (pi=0.42, p=0. 007). Linear regression analysis using all three types of sib pairs yielded a slope of -0.38 at p=0.00003. It seemed that the HLA effect was stronger in non-Jewish families than in Jewish families.
Conclusions: All available analytical methods support linkage of Crohn's disease to the MHC region in these Crohn's disease families. This region is estimated to contribute approximately 10-33% of the total genetic risk to Crohn's disease.
Shani U, Ben-Shabat N, Qassem R, Lahat A, Omar M, Savin E Therap Adv Gastroenterol. 2024; 17:17562848241227037.
PMID: 38282955 PMC: 10822082. DOI: 10.1177/17562848241227037.
Therapeutic drug monitoring for biological medications in inflammatory bowel disease.
Cogan R, El-Matary B, El-Matary W Saudi J Gastroenterol. 2022; 28(5):322-331.
PMID: 35343213 PMC: 9752529. DOI: 10.4103/sjg.sjg_3_22.
Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.
Sheu T, Chiang B Int J Mol Sci. 2021; 22(8).
PMID: 33923792 PMC: 8073364. DOI: 10.3390/ijms22084152.
Iwamoto T, Yashima K, Morio K, Ueda N, Ikebuchi Y, Kawaguchi K Yonago Acta Med. 2018; 61(1):27-32.
PMID: 29599619 PMC: 5871723.
Psoriasis and inflammatory bowel disease: links and risks.
Vlachos C, Gaitanis G, Katsanos K, Christodoulou D, Tsianos E, Bassukas I Psoriasis (Auckl). 2018; 6:73-92.
PMID: 29387596 PMC: 5683131. DOI: 10.2147/PTT.S85194.